Healthcare -
Biotechnology - NASDAQ - US
$ 1.36
0 %
$ 87.4 M
Market Cap
-0.88
P/E
INZY - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss INZY - Inozyme Pharma, Inc.
41 K
LAST VALUE
50.92%
2 YEAR CAGR
86.40%
5 YEAR CAGR
0.00%
10 YEAR CAGR